US Broker Ratings

Neogen Corporation (NEOG) Stock Analysis: Navigating Challenges with a 13% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a notable player in the healthcare sector, specifically within the diagnostics and research industry, continues to capture investor attention despite facing significant..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Marvel with a 68.70% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS) is capturing the attention of investors with its promising growth trajectory in the biotechnology sector. Based in Naarden, Netherlands, this late-stage..

Progyny, Inc. (PGNY) Stock Analysis: Evaluating a 19.35% Potential Upside in Healthcare Innovation

Progyny, Inc. (NASDAQ: PGNY), a pioneering company in the healthcare sector, specializes in offering comprehensive fertility and family-building benefits. With a market capitalization of $2.04 billion,..

MannKind Corporation (MNKD): Investor Outlook with Over 100% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company with a market cap of $1.41 billion, has been making waves in the biotechnology sector, particularly in the development..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring an 80% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector, specifically in the medical devices industry, has caught the eye of investors with..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a Complex Landscape with a Tempting Forward P/E of 1.74

Bausch Health Companies Inc. (NYSE: BHC), headquartered in Laval, Canada, is a multifaceted player in the healthcare sector, primarily focusing on specialty and generic drug manufacturing...

Select Medical Holdings Corp (SEM) Stock Analysis: Capturing a Potential Upside of 37%

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, is renowned for its expansive network of critical illness recovery hospitals, rehabilitation hospitals,..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: A 104% Upside Potential in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector with an impressive potential upside of 104.08%, as per analysts’ consensus. With a current market..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 67% Potential Upside Amidst Market Challenges

As Novavax, Inc. (NASDAQ: NVAX) navigates the volatile waters of the biotechnology sector, individual investors are eyeing a compelling 67% potential upside. This Gaithersburg, Maryland-based company..

Ocular Therapeutix, Inc. (OCUL): Investor Outlook Reveals 42.95% Potential Upside in Biotech Innovator

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a pioneering biopharmaceutical entity within the healthcare sector, offers a compelling case for investors with its innovative approach to treating ocular..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth in a Challenging Healthcare Landscape

Pediatrix Medical Group, Inc. (NYSE: MD) is a significant player in the healthcare sector, specializing in newborn and maternal-fetal care services across the United States. With..

Teladoc Health (TDOC) Stock Analysis: Navigating Virtual Healthcare’s Future with an 18% Upside Potential

Teladoc Health, Inc. (NYSE: TDOC) is a prominent player in the rapidly evolving virtual healthcare domain, offering a diverse array of services that span general medical..

Enovis Corporation (ENOV) Stock Analysis: Unpacking the 68.93% Potential Upside

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity with a significant potential..

Vera Therapeutics, Inc. (VERA): Investor Outlook on a Biotech with 194% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is drawing considerable attention in the healthcare sector as a promising player in the biotechnology industry. With a market capitalization of..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech With 32.47% Potential Upside

Liquidia Corporation (NASDAQ: LQDA) stands out in the biotechnology sector with its innovative approach to unmet patient needs, particularly in the field of pulmonary hypertension. Based..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25.52% Upside Potential Beckons Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is capturing investor attention with a promising potential upside of 25.52%. This global biopharmaceutical entity,..

Alvotech (ALVO) Stock Analysis: A Potential 116.85% Upside in the Healthcare Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company, is gaining significant attention from investors seeking opportunities within the healthcare sector, particularly in the niche market of biosimilar..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Evaluating the 37.59% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands at the intersection of biotechnology and cutting-edge technology, presenting both challenges and opportunities for investors. With a market capitalization of..

Amicus Therapeutics, Inc. (FOLD) Investor Outlook: Exploring a 112% Potential Upside with Analyst Confidence

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a notable player in the biotechnology sector, presents a compelling case for investors with a striking potential upside of 112% based..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a Potential 123% Upside in Biotech

In the high-stakes arena of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of investors with a compelling narrative and potential upside of 123.34%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds